Stem Cell And Stem Cell-Derived Extracellular Vesicles: Therapeutic Potential And Mechanistic Insights In Anti-Aging
As we age, our bodies undergo various changes that can lead to a decline in health and an increased risk of chronic diseases. Scientists are exploring new ways to combat these effects, and one exciting area of research involves tiny messengers released by cells, called extracellular vesicles (EVs). These microscopic packages carry important molecules like proteins, fats, and genetic material, acting as communication tools between cells.
While stem cells themselves hold great potential for regeneration, their direct use in therapies can be limited by concerns such as immune reactions, the risk of tumor formation, and ethical considerations. This is where EVs come in. Researchers have found that EVs derived from young or stem-like cells can offer many of the same rejuvenating and healing benefits as their parent cells, but with significantly reduced risks.
These tiny vesicles work by influencing key biological processes linked to aging, such as improving the function of our cells’ powerhouses (mitochondria), controlling inflammation, and supporting the health of our body’s own repair systems. Studies in laboratories and animals have shown that these vesicles can help with conditions like nerve damage, wound healing, muscle and bone issues, and widespread inflammation.
However, before these promising therapies can become widely available, there are still challenges to address. These include finding the best ways to produce these vesicles consistently, ensuring their quality, and conducting thorough safety and effectiveness tests in various disease models and human trials. Overcoming these hurdles will be crucial for bringing these innovative treatments from the lab to patients.
Source: link to paper